[ser140]-plp acetate

[SER140]-PLP(139-151) acetate is a peptide fragment from myelin proteolipid protein (PLP).

H-Ser-His-OH acetate is an endogenous metabolite hydrolysis cleavage activity.

Arg-Gly-Glu-Ser acetate is a RGD related peptide that is a control for the RGDS activity of fibrinogen binding to activated platelets.

Arg-Gly-Asp-Ser acetate is an integrin binding sequence that directly and specifically bind pro-caspase-8, pro-caspase-9 and pro-caspase-3, while it does not bind pro-caspase-1. Arg-Gly-Asp-Ser acetate inhibits integrin receptor function.

Fmoc-Gly-Ser(psi(Me,Me)pro)-OH acetate is a dipeptide.

Gly-Arg-Gly-Asp-Ser (GRGDS) acetate is a cell binding protein domain derived from the cell-binding region of fibronectin.

[SER140]-PLP(139-151) is a polypeptide fragment of the lipid protein of myelin.

[SER140]-PLP(139-151) (TFA) is a polypeptide fragment of the myelin lipid protein.

N-Acetyl-Ser-Asp-Lys-Pro (Ac-SDKP) acetate, a specific substrate for the N-terminal active site of angiotensin-converting enzyme (ACE), functions as a natural inhibitor of pluripotent hematopoietic stem cell proliferation. Additionally, it exhibits anti-inflammatory and antifibrotic properties [1] [2].